Editas Medicine, Inc. EDIT

Set alert

Price alert · EDIT

All alert types
2.57 USD -0.10 -3.75%

At close

2.74 +0.17 +6.58%

Pre-market · Nov 3, 8:38 AM ET

Bid
2.56 × 1
Ask
2.57 × 1
2.55 Day range 2.78
1.66 52-week range 3.94
YTD
+25.37%
1 year
-16.01%
Open
2.71
Prev close
2.67
Mkt cap
394.70M
Vol
1.24M
Avg vol
2.69M
EPS
-0.68
P/E
0.00
Div yield
0.00%
More statistics
Low
2.55
High
2.78
Forward P/E
-0.53
Beta
2.01
Short ratio
6.70
Inst. own
70.94%
Dividend
0.00
Ex-div date
50-d avg
2.60
200-d avg
4.55
1y target
3.67

MAX chart

Chart tools
Interval

Events in this range
  • Aug 2, 2023Earnings: -0.56; estimate -0.76; surprise 26.32%
  • Nov 3, 2023Earnings: -0.55; estimate -0.64; surprise 14.06%
  • Aug 7, 2024Earnings: -0.82; estimate -0.69; surprise -18.84%
  • Nov 4, 2024Earnings: -0.75; estimate -0.76; surprise 1.32%
Signals (39)
NameDateAgo
SMA: BearishSep 1, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BullishAug 1, 20263 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishJun 1, 20251 year ago
SMA: BearishMar 1, 20242 years ago
SMA: BullishFeb 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishNov 1, 20233 years ago
SMA: BearishSep 1, 20233 years ago
SMA: BullishAug 1, 20233 years ago
MACD: Buy SignalJul 1, 20233 years ago
SMA: BearishNov 1, 20215 years ago
MACD: Sell SignalOct 1, 20215 years ago
SMA: BearishSep 1, 20215 years ago
SMA: BullishAug 1, 20215 years ago
SMA: BearishJul 1, 20215 years ago

Newest 20 of 39.

Analyst view

Consensus: hold

Hold
Price target (mean) 3.67 +42.7% upside
Target (low)
1.00
Target (mean)
3.67
Target (high)
8.00
Ratings (0m) 18 4 buy · 12 hold · 2 sell
  • Strong buy0
  • Buy4
  • Hold12
  • Sell0
  • Strong sell2

Recommendation trend

  • This month 18
  • 1 month ago 19
  • 2 months ago 19
  • 3 months ago 19

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

EDIT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.3561-0.87 – 0.10-0.23-54.8%36.02M-40.0%15
Next quarter-0.52731-0.83 – -0.33-0.76+30.6%808.71K-28.7%8
Current year-2.68-3.20 – -2.20-2.02-32.5%43.36M-44.5%15
Next year-1.50-3.31 – -0.17-2.68+44.1%20.87M-51.9%15

Upgrades and downgrades

The latest rating changes

EDIT analyst upgrades and downgrades
DateFirmActionFromTo
Dec 16, 2024Evercore ISI GroupMaintainedOutperformOutperform
Dec 16, 2024JP MorganDowngradeNeutralUnderweight
Dec 13, 2024RBC CapitalMaintainedSector PerformSector Perform
Dec 13, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Dec 13, 2024Chardan CapitalDowngradeBuyNeutral
Dec 13, 2024BairdMaintainedOutperformOutperform
Dec 13, 2024StifelDowngradeBuyHold
Dec 11, 2024Wells FargoDowngradeOverweightEqual-Weight
Nov 5, 2024Chardan CapitalMaintainedBuyBuy
Nov 5, 2024RBC CapitalMaintainedSector PerformSector Perform
Nov 5, 2024StifelMaintainedBuyBuy
Nov 5, 2024Truist SecuritiesMaintainedBuyBuy
Nov 5, 2024Wells FargoMaintainedOverweightOverweight
Nov 5, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Oct 23, 2024Evercore ISI GroupMaintainedIn-LineIn-Line
Oct 23, 2024Wells FargoMaintainedOverweightOverweight
Oct 22, 2024Chardan CapitalMaintainedBuyBuy
Sep 19, 2024RBC CapitalReiteratedSector PerformSector Perform
Sep 17, 2024Jones TradingInitiated—Buy
Aug 8, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Aug 8, 2024Truist SecuritiesMaintainedBuyBuy
Aug 8, 2024B of A SecuritiesUpgradeNeutralBuy
Jun 18, 2024OppenheimerMaintainedPerformPerform
May 30, 2024Evercore ISI GroupMaintainedIn-LineIn-Line
May 9, 2024CitigroupMaintainedBuyBuy
May 9, 2024Morgan StanleyUpgradeUnderweightEqual-Weight
May 9, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Feb 29, 2024CitigroupMaintainedBuyBuy
Feb 29, 2024BarclaysMaintainedEqual-WeightEqual-Weight
Feb 27, 2024JP MorganMaintainedNeutralNeutral